Immunomedics, Inc. (NASDAQ:IMMU) shares were trading lower by -0.45 percent ($-0.05) at $11.1 a piece in Monday’s session. It had closed the previous session at $11.15. IMMU trades with a P/S ratio of 555.93. This compares with the industry’s 94.01 and the wider sector’s 5.36. A low price-to-sales ratio, typically less than 1.0, is considered a good value. . Shares of IMMU have downtrended -6.25% in the past three months. Immunomedics, Inc. (IMMU) has a market cap of $1.67 billion and over the last 12 months, Immunomedics, Inc. (NASDAQ:IMMU) has gone stronger by 219.88%. During the last 52 weeks, the (NASDAQ:IMMU) price has been as high as $14.48 and as low as $3.01. Immunomedics, Inc. earnings have declined with an annualized rate of -44.67% over the last 5 years. The average 1-year price target for Immunomedics, Inc. (IMMU) — averaging the work of different analysts — reveals a mean PT of $15/share. That’s a potential 35.14 increase relative to where Immunomedics, Inc. (NASDAQ:IMMU) has been trading recently. The current price is seen ranging between $11.04 and $11.54. There are brokerage firms with lower targets than the average, including one setting a price target of $14. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $16. The collective rating of 1.3 for Immunomedics, Inc. (NASDAQ:IMMU) also leans strongly towards the bullish end of the spectrum. Of the 3 analysts surveyed by Reuters that track IMMU 0 of them rate its stock a hold. The other 3, though not evenly; between analysts who think you should buy Immunomedics, Inc. versus those who think you should sell it. A 3 analysts rate it as either a buy or a strong buy, while0 believe that investors should either steer clear of IMMU or, if they already own its stock, sell it. Philip Morris International Inc. (PM) knifed -0.45 percent lower and now trades for $102.72. PM comes in with a P/S ratio of 5.84 that’s greater than 1, potentially implying that it could be expensive relative to the overall sector (6.14) and its peers (4.41). Also, it has an estimated price-earnings (P/E) multiple of 19.38 and a trailing 12-month price-earnings (P/E) multiple of 22.66. During the last 52 weeks, the price has been as high as $123.55 and as low as $86.78. Philip Morris International Inc. (NYSE:PM) earnings have declined with a quarterly rate of -3% over the last 5 years. Shares of PM have sank -11.1% in the past three monthswhile the S&P 500 has dropped -15.63% in that time. Philip Morris International Inc. (NYSE:PM) has a market cap of $160.1 billion and over the last 12 months, PM has risen by 15.04%. The average 1-year price target for (PM) reveals an average price target of $121.35 per share. That’s a potential 18.14 gain from where (NYSE:PM) has been trading recently. There are brokerage firms with lower targets than the average, including one setting a price target of $98. And then on the other side of the spectrum one analyst entrenched in the bullish camp has a target as high as $135. The consensus recommendation — averaging the work of 18 analysts — of 2.4 for Philip Morris International Inc. (PM) points to moderate case. Of the analysts surveyed by Reuters that track Philip Morris International Inc. 9 of them rate its stock a hold. The other 9 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it. A 9 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NYSE:PM) or, if they already own its stock, sell it.




(adsbygoogle = window.adsbygoogle || []).push({});
